230 related articles for article (PubMed ID: 19936329)
1. Use of HIV as a gene transfer vector.
Pluta K; Kacprzak MM
Acta Biochim Pol; 2009; 56(4):531-95. PubMed ID: 19936329
[TBL] [Abstract][Full Text] [Related]
2. Lentiviral vectors: are they the future of animal transgenesis?
Park F
Physiol Genomics; 2007 Oct; 31(2):159-73. PubMed ID: 17684037
[TBL] [Abstract][Full Text] [Related]
3. Hybrid HIV/MSCV LTR enhances transgene expression of lentiviral vectors in human CD34(+) hematopoietic cells.
Choi JK; Hoang N; Vilardi AM; Conrad P; Emerson SG; Gewirtz AM
Stem Cells; 2001; 19(3):236-46. PubMed ID: 11359949
[TBL] [Abstract][Full Text] [Related]
4. Effective transduction and stable transgene expression in human blood cells by a third-generation lentiviral vector.
Bai Y; Soda Y; Izawa K; Tanabe T; Kang X; Tojo A; Hoshino H; Miyoshi H; Asano S; Tani K
Gene Ther; 2003 Aug; 10(17):1446-57. PubMed ID: 12900759
[TBL] [Abstract][Full Text] [Related]
5. Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors.
Sirven A; Ravet E; Charneau P; Zennou V; Coulombel L; Guétard D; Pflumio F; Dubart-Kupperschmitt A
Mol Ther; 2001 Apr; 3(4):438-48. PubMed ID: 11319904
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte-specific gene expression from integrated lentiviral vectors.
Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM
J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070
[TBL] [Abstract][Full Text] [Related]
7. Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors.
McKay T; Patel M; Pickles RJ; Johnson LG; Olsen JC
Gene Ther; 2006 Apr; 13(8):715-24. PubMed ID: 16397505
[TBL] [Abstract][Full Text] [Related]
8. An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins.
Pacchia AL; Adelson ME; Kaul M; Ron Y; Dougherty JP
Virology; 2001 Mar; 282(1):77-86. PubMed ID: 11259192
[TBL] [Abstract][Full Text] [Related]
9. Expression from second-generation feline immunodeficiency virus vectors is impaired in human hematopoietic cells.
Price MA; Case SS; Carbonaro DA; Yu XJ; Petersen D; Sabo KM; Curran MA; Engel BC; Margarian H; Abkowitz JL; Nolan GP; Kohn DB; Crooks GM
Mol Ther; 2002 Nov; 6(5):645-52. PubMed ID: 12409263
[TBL] [Abstract][Full Text] [Related]
10. Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.
Yamada K; Olsen JC; Patel M; Rao KW; Walsh CE
Mol Ther; 2001 Apr; 3(4):485-90. PubMed ID: 11319908
[TBL] [Abstract][Full Text] [Related]
11. Defective lentiviral vectors are efficiently trafficked by HIV-1 and inhibit its replication.
Klimatcheva E; Planelles V; Day SL; Fulreader F; Renda MJ; Rosenblatt J
Mol Ther; 2001 Jun; 3(6):928-39. PubMed ID: 11407907
[TBL] [Abstract][Full Text] [Related]
12. Lentiviral vectors for enhanced gene expression in human hematopoietic cells.
Ramezani A; Hawley TS; Hawley RG
Mol Ther; 2000 Nov; 2(5):458-69. PubMed ID: 11082319
[TBL] [Abstract][Full Text] [Related]
13. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
[TBL] [Abstract][Full Text] [Related]
14. Retroviral vectors for gene therapy of AIDS and cancer.
Chang LJ; He J
Curr Opin Mol Ther; 2001 Oct; 3(5):468-75. PubMed ID: 11699891
[TBL] [Abstract][Full Text] [Related]
15. Lentiviral transduction of human hematopoietic cells by HIV-1- and SIV-based vectors containing a bicistronic cassette driven by various internal promoters.
Dupuy FP; Mouly E; Mesel-Lemoine M; Morel C; Abriol J; Cherai M; Baillou C; Nègre D; Cosset FL; Klatzmann D; Lemoine FM
J Gene Med; 2005 Sep; 7(9):1158-71. PubMed ID: 15880619
[TBL] [Abstract][Full Text] [Related]
16. High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector.
Gao Z; Golob J; Tanavde VM; Civin CI; Hawley RG; Cheng L
Stem Cells; 2001; 19(3):247-59. PubMed ID: 11359950
[TBL] [Abstract][Full Text] [Related]
17. Design and in vivo characterization of self-inactivating human and non-human lentiviral expression vectors engineered for streptogramin-adjustable transgene expression.
Mitta B; Weber CC; Rimann M; Fussenegger M
Nucleic Acids Res; 2004 Jul; 32(12):e106. PubMed ID: 15258250
[TBL] [Abstract][Full Text] [Related]
18. Self-inactivating lentiviral vectors with U3 and U5 modifications.
Iwakuma T; Cui Y; Chang LJ
Virology; 1999 Aug; 261(1):120-32. PubMed ID: 10441560
[TBL] [Abstract][Full Text] [Related]
19. Modified HIV-1 based lentiviral vectors have an effect on viral transduction efficiency and gene expression in vitro and in vivo.
Park F; Kay MA
Mol Ther; 2001 Sep; 4(3):164-73. PubMed ID: 11545606
[TBL] [Abstract][Full Text] [Related]
20. [Lentiviral vectors].
Spirin PV; Vil'gelm AE; Prasolov VS
Mol Biol (Mosk); 2008; 42(5):913-26. PubMed ID: 18988539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
